Michael C. Iannuzzi

Active 1987–2023

34
Papers
19,624
Citations
32
h-index
34
i10-index

Citations

Citations per year for Michael C. Iannuzzi1981: 1 citations1987: 4 citations1988: 2 citations1989: 10 citations1990: 104 citations1991: 155 citations1992: 183 citations1993: 117 citations1994: 131 citations1995: 91 citations1996: 77 citations1997: 70 citations1998: 67 citations1999: 88 citations2000: 81 citations2001: 76 citations2002: 70 citations2003: 85 citations2004: 73 citations2005: 94 citations2006: 69 citations2007: 103 citations2008: 127 citations2009: 95 citations2010: 97 citations2011: 108 citations2012: 126 citations2013: 115 citations2014: 94 citations2015: 121 citations2016: 78 citations2017: 101 citations2018: 94 citations2019: 342 citations2020: 344 citations2021: 241 citations2022: 168 citations2023: 139 citations2024: 179 citations2025: 80 citations2026: 3 citations1982–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,721 citing papers, 36.8% of this breakdownUnited Kingdom: 390 citing papers, 8.3% of this breakdownCanada: 322 citing papers, 6.9% of this breakdownFrance: 257 citing papers, 5.5% of this breakdownGermany: 253 citing papers, 5.4% of this breakdownItaly: 198 citing papers, 4.2% of this breakdownNetherlands: 184 citing papers, 3.9% of this breakdownAustralia: 105 citing papers, 2.3% of this breakdownChina: 95 citing papers, 2% of this breakdownJapan: 95 citing papers, 2% of this breakdownBelgium: 91 citing papers, 2% of this breakdownSweden: 91 citing papers, 2% of this breakdown
0%36.8%Other 18.7%

Fields

  • Medicine76.6%
  • Biochemistry, Genetics and Molecular Biology18.3%
  • Immunology and Microbiology1.3%
  • Agricultural and Biological Sciences0.9%
  • Neuroscience0.9%
  • Environmental Science0.5%
  • Other1.5%

Topics

  • Cystic Fibrosis Research Advances14.5%
  • Sarcoidosis and Beryllium Toxicity Research8.1%
  • Neonatal Respiratory Health Research7.5%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis6.3%
  • Tracheal and airway disorders2.4%
  • Drug Transport and Resistance Mechanisms2.3%
  • Other58.9%

Coauthors

All papers

Open in search
  1. Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA

    Authors: , , , , , , , , , , , , , - Science 1989 cited by 7,446

  2. Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis

    Authors: , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2001 cited by 1,804

  3. Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping

    Authors: , , , , , , , , , , , , , , - Science 1989 cited by 3,252

  4. A Case Control Etiologic Study of Sarcoidosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2004 cited by 799

  5. Sarcoidosis

    Authors: , , - New England Journal of Medicine 2007 cited by 1,950

  6. Occupational Risk Factors for Sarcoidosis in African-American Siblings

    Authors: , , , , , , - CHEST Journal 2003 cited by 142

  7. Job and Industry Classifications Associated With Sarcoidosis in a Case–Control Etiologic Study of Sarcoidosis (ACCESS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Occupational and Environmental Medicine 2005 cited by 129

  8. Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wolfgang Lieb, Almut Nebel, Joachim Müller–Quernheim, André Franke, Stefan Schreiber - American Journal of Respiratory and Critical Care Medicine 2015 cited by 123

  9. A cystic fibrosis pancreatic adenocarcinoma cell line.

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1990 cited by 242

  10. Familial Aggregation of Sarcoidosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2001 cited by 451

  11. HLA-DRB1*1101: A Significant Risk Factor for Sarcoidosis in Blacks and Whites

    Authors: , , , , , , , , , , - The American Journal of Human Genetics 2003 cited by 386

  12. Sarcoidosis Susceptibility and Resistance HLA-DQB1 Alleles in African Americans

    Authors: , , , - American Journal of Respiratory and Critical Care Medicine 2003 cited by 139

  13. Sarcoidosis: Pitfalls and Challenging Mimickers

    Authors: , - Frontiers in Medicine 2021 cited by 42

  14. Familial Risk Ratio of Sarcoidosis in African-American Sibs and Parents

    Authors: , , , , , , - American Journal of Epidemiology 2001 cited by 101

  15. Pulmonary and psychosocial findings at enrollment in the ACCESS study.

    Authors: , , , , , , , , , , , , , , , , , , - 2005 cited by 92

  16. High-Density Genetic Mapping Identifies New Susceptibility Variants in Sarcoidosis Phenotypes and Shows Genomic-driven Phenotypic Differences

    Authors: , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2015 cited by 90

  17. Genome-Wide Association Study of Ocular Sarcoidosis Confirms HLA Associations and Implicates Barrier Function and Autoimmunity in African Americans

    Authors: , , , , , , , , , - Ocular Immunology and Inflammation 2020 cited by 31

  18. Epidemiology of Sarcoidosis: Recent Advances and Future Prospects

    Authors: , - Seminars in Respiratory and Critical Care Medicine 2007 cited by 152

  19. Genome-Wide Association Study of African and European Americans Implicates Multiple Shared and Ethnic Specific Loci in Sarcoidosis Susceptibility

    Authors: , , , , , , , , , , , , , , , - PLoS ONE 2012 cited by 122

  20. Use of fluticasone in acute symptomatic pulmonary sarcoidosis.

    Authors: , , , , , , - 2002 cited by 105

  21. USH2A Gene Mutations in Rabbits Lead to Progressive Retinal Degeneration and Hearing Loss

    Authors: , , , , , , , , , , , , , , , , - Translational Vision Science & Technology 2023 cited by 16

  22. Results of 188 Whole-Body Fluorodeoxyglucose Positron Emission Tomography Scans in 137 Patients With Sarcoidosis

    Authors: , , , , , - CHEST Journal 2007 cited by 325

  23. The BTNL2 Gene and Sarcoidosis Susceptibility in African Americans and Whites

    Authors: , , , , - The American Journal of Human Genetics 2005 cited by 218

  24. Radiation Therapy for the Treatment of Unresected Stage I-II Non-small Cell Lung Cancer

    Authors: , , , , - CHEST Journal 2005 cited by 174